Acumen Pharmaceuticals, Inc.
ABOS
$0.98
-$0.008-0.81%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -37.15M | -29.77M | -20.54M | -14.87M | -16.50M |
| Total Depreciation and Amortization | 44.00K | 45.00K | 45.00K | 44.00K | 39.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.67M | 1.39M | 182.00K | 1.04M | 2.09M |
| Change in Net Operating Assets | 8.22M | 3.73M | 3.77M | -4.07M | 6.05M |
| Cash from Operations | -27.22M | -24.60M | -16.55M | -17.86M | -8.31M |
| Capital Expenditure | 0.00 | 0.00 | -5.00K | -11.00K | -14.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | 0.00 |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 29.66M | -10.13M | 37.70M | -9.19M | -48.79M |
| Cash from Investing | 29.66M | -10.13M | 37.70M | -9.20M | -48.81M |
| Total Debt Issued | -- | -- | -- | -- | 30.00M |
| Total Debt Repaid | 0.00 | 0.00 | 0.00 | -739.00K | -- |
| Issuance of Common Stock | 0.00 | 0.00 | 0.00 | 7.94M | -- |
| Repurchase of Common Stock | -9.00K | 0.00 | 0.00 | -32.00K | -390.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | -42.00K | -128.00K | -60.00K | -476.00K |
| Cash from Financing | -9.00K | -42.00K | -128.00K | 7.11M | 29.13M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.44M | -34.77M | 21.03M | -19.96M | -27.99M |
